The DOI matches its Crossref record.
Dexamethasone Inhibits Growth Hormone Induction of Insulin-Like Growth Factor-I (IGF-I) Messenger Ribonucleic Acid (mRNA) in Hypophysectomized Rats and Reduces IGF-I mRNA Abundance in the Intact Rat*
Abstract
Exogenous glucocorticoids are potent inhibitors of skeletal growth in experimental animals and children. The mechanism whereby glucocorticoids exert this effect is unclear, and circulating somatomedin levels have been reported to be low, normal, or high in this situation. Since recent studies have emphasized the importance of autocrine or paracrine insulin-like growth factor I (IGF-I), we have examined the effects of dexamethasone (DXM) on IGF-I gene expression in the hypophysectomized (hypox) and pituitary intact rat. An increase in IGF-I messenger RNA (mRNA) abundance of approximately 5-, 3-, 2-, and 1.5-fold in the liver, proximal tibia, lung, and kidney, respectively, was seen in hypox rats killed 6 h after injection of human GH (100 micrograms/100 g body wt). As little as 1 micrograms/100 g body wt of DXM administered 3 h before GH injection significantly reduced GH induction of IGF-I mRNA in the liver and the proximal tibia (P less than 0.05 and P less than 0.005, respectively). Higher doses of DXM were required to reduce IGF-I mRNA abundance in the kidney and lung. Of the tissues examined the order of sensitivity to DXM was liver greater than tibia greater than kidney greater than lung. In contrast to the effects of DXM on tissue IGF-I mRNA abundance, an approximately 10-fold higher dose of DXM was required to inhibit the GH-induced rise in serum IGF-I concentration. The effect of DXM on steady state IGF-I mRNA abundance in pituitary-intact rats which were killed 9 h after DXM was also examined. The reduction in IGF-I mRNA abundance required higher doses of DXM (6-360 micrograms/100 g body wt) and was less marked in pituitary-intact rats than in GH-treated hypox rats. In the pituitary-intact rats the order of sensitivity to DXM was tibia greater than liver greater than lung greater than kidney. In acute studies serum IGF-I levels were not decreased by any dose of DXM; rather a significant increase in serum IGF-I was apparent in pituitary intact rats, treated with the lowest and highest doses of DXM. When DXM was administered daily for 6 days to pituitary intact rats, body wt gain and hepatic and tibial IGF-I mRNA abundance were significantly reduced. No significant changes were seen in serum IGF-I concentrations.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Systemic and Local Regulation of the Growth Plate
van der Eerden, B. C. J., Karperien, M., & Wit, J. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0033 · Cited by 558
Insulin-like growth factor binding proteins and their role in controlling IGF actions
Clemmons, D. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00053-6 · Cited by 498
Butler, A. A., & Roith, D. L. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.141 · Cited by 385
MURPHY, L. J., & GHAHARY, A. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-3-443 · Cited by 305
Self-citationStructure, Evolution, Expression and Regulation of Insulin-Like Growth Factors I and II
Rotwein, P. (1991) · Growth Factors · doi:10.3109/08977199109000267 · Cited by 252
Metadata
- Authors
- LUO, J., & MURPHY, L. J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1989-07
- Volume
- 125
- Issue
- 1
- Pages
- 165-171
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2007817553
- Cited by
- 167
- References
- 0
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dexamethasone Inhibits Growth Hormone Induction of Insulin-Like Growth Factor-I (IGF-I) Messenger Ribonucleic Acid (mRNA) in Hypophysectomized Rats and Reduces IGF-I mRNA Abundance in the Intact Rat*. https://app.cochat.ai/papers/10.1210/endo-125-1-165
- The paper
- LUO, J., & MURPHY, L. J. (1989). Dexamethasone Inhibits Growth Hormone Induction of Insulin-Like Growth Factor-I (IGF-I) Messenger Ribonucleic Acid (mRNA) in Hypophysectomized Rats and Reduces IGF-I mRNA Abundance in the Intact Rat*. Endocrinology. https://doi.org/10.1210/endo-125-1-165
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.